Menu

Study: Climate Change Could Threaten Tardigrades

Researchers find that a combination of high temperatures and UV radiation can have negative effects on these hardy creatures.

Dec 20, 2017
Diana Kwon

ISTOCK, ERAXIONTardigrades—microscopic animals that can survive extreme temperatures, years of dehydration, and even a trip to outer space—might not be able to withstand the combined effects of climate change, according to a study published last week (December 14) in the Journal of Experimental Biology.

Scientists at the University of Modena and Reggio Emilia in Italy examined how Acutuncus antarcticus, a tardigrade species native to the Antarctic, would react to climate change–associated stressors such as dehydration, high temperatures, and increased levels of ultraviolet (UV) radiation. While the organisms were able to cope with individual events, a combination of high temperatures and high radiation lowered their chances of survival. 

In addition, the researchers report that tardigrades born from UV-irradiated eggs took longer to reach sexual maturity and produced fewer eggs during their lifetime than those hatched from nonirradiated eggs.

It is not certain that UV radiation at the poles will get worse than it is today, Mark Blaxter, a biologist at the University of Edinburgh who did not take part in the work, tells New Scientist. “Whether this tardigrade is more at risk than, say, apex predators such as penguin, or ecosystem keystones such as krill, is not clear,” he adds.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

Cell culture made easy with new 24-channel pipetting heads for VIAFLO 96/384
Cell culture made easy with new 24-channel pipetting heads for VIAFLO 96/384
INTEGRA has responded to customers’ requests and developed two new 24-channel pipetting heads, extending the capabilities of its popular VIAFLO 96/384.
Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its CRISPR Screening Service to includeex vivoT lymphocytes. The service extension meets the requirements of immunology-based research in drug discovery,enabling new gene targets to be identified in biologically and potentially therapeutically relevant settings.
pIC50: The Advantages of Thinking Logarithmically
pIC50: The Advantages of Thinking Logarithmically
Watch this webinar from Collaborative Drug Discovery to learn about how using pIC50 helps you get a better sense of the relative potencies, calculate the correct mean of multiple values, and select better sampling doses.
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.